Figure 5From: A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumors Kaplan–Meier plot of overall survival. * The Kaplan–Meier method was applied only for dose-level groups with at least 6 patients.Back to article page